BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23276383)

  • 41. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
    Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
    Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A pony with a metastasized hemangiosarcoma].
    Geelen SN; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 1996 Oct; 121(19):544-6. PubMed ID: 8966699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary splenic peripheral nerve sheath tumour in a dog.
    Bergmann W; Burgener IA; Roccabianca P; Rytz U; Welle M
    J Comp Pathol; 2009; 141(2-3):195-8. PubMed ID: 19477462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour suppressor gene p53 mutation in a case of haemangiosarcoma of a dog.
    Mayr B; Zwetkoff S; Schaffner G; Reifinger M
    Acta Vet Hung; 2002; 50(2):157-60. PubMed ID: 12113170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canine Cutaneous Haemangiosarcoma: Biomarkers and Survival.
    Nóbrega DF; Sehaber VF; Madureira R; Bracarense APFRL
    J Comp Pathol; 2019 Jan; 166():87-96. PubMed ID: 30691610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of pathological diagnoses made from 87 canine splenic biopsies.
    Day MJ; Lucke VM; Pearson H
    J Small Anim Pract; 1995 Oct; 36(10):426-33. PubMed ID: 8583757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved detection of metastatic hepatic hemangiosarcoma nodules with contrast ultrasound in three dogs.
    O'Brien RT
    Vet Radiol Ultrasound; 2007; 48(2):146-8. PubMed ID: 17385374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy.
    Johnson KA; Powers BE; Withrow SJ; Sheetz MJ; Curtis CR; Wrigley RH
    J Vet Intern Med; 1989; 3(3):160-6. PubMed ID: 2778749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histologic and immunohistochemical review of splenic fibrohistiocytic nodules in dogs.
    Moore AS; Frimberger AE; Sullivan N; Moore PF
    J Vet Intern Med; 2012; 26(5):1164-8. PubMed ID: 22882592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is your diagnosis? Primary splenic tumor and suppurative peritonitis due to gallbladder rupture.
    Ramirez O; Bliss S
    J Am Vet Med Assoc; 1999 Mar; 214(5):625-6. PubMed ID: 10088007
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum angiopoietin-2 levels in dogs with splenic haemangiosarcoma, haemangioma, and splenitis.
    Wongsuttawas S; Brikshavana P; Durongphongtorn S; Techangamsuwan S
    Acta Vet Hung; 2021 May; 69(1):55-66. PubMed ID: 33964126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical analysis of the Akt/mTOR/4E-BP1 signalling pathway in canine haemangiomas and haemangiosarcomas.
    Murai A; Abou Asa S; Kodama A; Sakai H; Hirata A; Yanai T
    J Comp Pathol; 2012 Nov; 147(4):430-40. PubMed ID: 22789858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
    Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
    Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasonographic features of splenic hemangiosarcoma in dogs: 18 cases (1980-1986).
    Wrigley RH; Park RD; Konde LJ; Lebel JL
    J Am Vet Med Assoc; 1988 Apr; 192(8):1113-7. PubMed ID: 3286591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
    Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
    Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary mesenchymal (nonangiomatous/nonlymphomatous) neoplasms occurring in the canine spleen: anatomic classification, immunohistochemistry, and mitotic activity correlated with patient survival.
    Spangler WL; Culbertson MR; Kass PH
    Vet Pathol; 1994 Jan; 31(1):37-47. PubMed ID: 8140724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007-2008).
    Mallinckrodt MJ; Gottfried SD
    J Am Vet Med Assoc; 2011 Nov; 239(10):1325-7. PubMed ID: 22044329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules.
    Cole PA
    J Vet Diagn Invest; 2012 Jul; 24(4):759-62. PubMed ID: 22621950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma.
    O'Brien D; Moore PF; Vernau W; Peauroi JR; Rebhun RB; Rodriguez CO; Skorupski KA
    J Vet Intern Med; 2013; 27(4):949-54. PubMed ID: 23734665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Canine hemangiosarcoma: retrospective analysis of 104 cases.
    Brown NO; Patnaik AK; MacEwen EG
    J Am Vet Med Assoc; 1985 Jan; 186(1):56-8. PubMed ID: 4038395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.